Alendronate Versus Denosumab in Kidney Transplant Patients
Conditions: Osteoporosis, Osteopenia; Renal Transplant Recipient Interventions: Drug: Denosumab 60 mg/ml [Prolia]; Drug: Alendronate 70Mg Tab Sponsors: Ain Shams University; Nahda University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Kidney Transplant | Kidney Transplantation | Orthopaedics | Osteoporosis | Research | Transplant Surgery | Transplants | Urology & Nephrology | Xgeva